The Use of Other Drugs to Allow a Lower Dosage of Cyclosporin to Be Used
- 1 May 1997
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 32 (5), 357-367
- https://doi.org/10.2165/00003088-199732050-00002
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Survey of Cyclosporine Therapeutic Ranges, Assay Methodology, and Use of 'Sparing Agents' in Australasian Transplant CentersTherapeutic Drug Monitoring, 1997
- Diltiazem does not always increase blood cyclosporin concentration.1996
- Cost-containment strategies in transplantation: the utility of cyclosporine-ketoconazole combination therapy.1996
- A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group.1995
- Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantationThe Lancet, 1995
- Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.1994
- Cyclosporine pharmacokinetics in nephrotic and kidney-transplanted childrenEuropean Journal of Clinical Pharmacology, 1994
- Diltiazem improves cyclosporine dosage in cystic fibrosis lung transplant recipients.1994
- DILTIAZEM AND ECONOMIC USE OF CYCLOSPORINThe Lancet, 1986
- KETOCONAZOLE, CYCLOSPORIN METABOLISM, AND RENAL TRANSPLANTATIONThe Lancet, 1982